Home - Products - Chromatin/Epigenetic - Epigenetic Reader Domain - ZL0590

ZL0590

CAS No. 2230496-99-6

ZL0590( —— )

Catalog No. M28525 CAS No. 2230496-99-6

ZL0590 is an effective and selective inhibitor of BD1-BRD4 (IC50 = 90 nM) with anti-inflammatory activities.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	177	Get Quote
10MG	282	Get Quote
25MG	480	Get Quote
50MG	691	Get Quote
100MG	972	Get Quote
500MG	1944	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

ZL0590
Note

Research use only, not for human use.
Brief Description

ZL0590 is an effective and selective inhibitor of BD1-BRD4 (IC50 = 90 nM) with anti-inflammatory activities.
Description

ZL0590 is an effective and selective inhibitor of BD1-BRD4 (IC50 = 90 nM) with anti-inflammatory activities.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Chromatin/Epigenetic
Target

Epigenetic Reader Domain
Recptor

——
Research Area

——
Indication

——

Chemical Information

CAS Number

2230496-99-6
Formula Weight

512.55
Molecular Formula

C23H27F3N4O4S
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 100 mg/mL (195.10 mM)
SMILES

S(=O)(=O)(N1[C@H](CN2CCOCC2)CCC1)C3=CC=C(NC(NC4=CC=C(C(F)(F)F)C=C4)=O)C=C3
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

FLI-06

FLI-06 is a Notch signaling inhibitor (EC50: 2.3 μM).
Trotabresib

Trotabresib (CC-90010) is an orally active inhibitor of BET and can be used in studies about advanced solid tumors.
Y06137

Y06137 is an effective and selective BET inhibitor with a Kd of 81 nM for BRD4(1) bromodomain. Y06137 can be used for research on the treatment of castration-resistant prostate cancer.

Sign In Join Free